Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

real-world data

This page shows the latest real-world data news and features for those working in and with pharma, biotech and healthcare.

Lilly trumpets Trulicity heart data in face-off with Novo Nordisk

Lilly trumpets Trulicity heart data in face-off with Novo Nordisk

first nine months of the year, helped by data suggesting it is superior to Trulicity in maintaining glucose control when added to background treatment with metformin. ... Meanwhile Boehringer and Lilly also have new real-world data for Jardiance from a

Latest news

  • Safety first: AI adoption in the healthcare sector Safety first: AI adoption in the healthcare sector

    There are many variables to determine the quality of inputted data: are the data sets ‘big’ enough, is ‘real-world’ data being used, is the data corrupt, biased or discriminatory? ... At its most fundamental, this is about artificial systems

  • Artificial intelligence in healthcare Artificial intelligence in healthcare

    And applying AI to real-world evidence – another hot topic in pharma – could help companies predict performance of certain trial sites, anticipate drop outs and even predict outcomes. ... One example is a Novartis project with Watson to combine AI

  • AI company Sensyne raises £60m in IPO AI company Sensyne raises £60m in IPO

    guide the development of new drugs, as well as real-world evidence-based software to improve patient care and the conduct of clinical trials that could be of value to pharma ... The idea behind the software is that in addition to helping patients manage

  • Collaborate to survive Collaborate to survive

    To give an example, look at the opportunities presented by some of the converging trends in data and technology. ... Meanwhile, the promise of real-world data (RWD) is being realised. And what’s really interesting is that all of these things are

  • J&J’s Invokana aces diabetic kidney disease trial, setting up filings J&J’s Invokana aces diabetic kidney disease trial, setting up filings

    The data itself is being kept under wraps pending presentation at a medical conference, but J&J says it is preparing to run it past regulators as well. ... dapagliflozin). Since then J&J has been trying to restore confidence in its product – publishing

More from news
Approximately 13 fully matching, plus 80 partially matching documents found.

Latest Intelligence

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    data. The importance of real-world data is growing rapidly, but its quality, taxonomy and accessibility are not standardised and once again require collaboration to pull it off. ... An example is the real-world observational study GSK conducted for its

  • Brand teams: why are some smarter than others? Brand teams: why are some smarter than others?

    Although life sciences companies talk about having world-class commercial teams, the truth is rather more mundane. ... 3.  Testing, when the hypotheses developed from the explicated assumptions are tested against real-world data.

  • Reaching the new influencers Reaching the new influencers

    With payers looking increasingly to  real-world data,   and to differentiation beyond this data through outcomes commitment and the provision of beyond the pill services, there’s never been a ... The growth in availability and importance of

  • Brave real world? How healthcare communication needs to adapt Brave real world? How healthcare communication needs to adapt

    the stresses and strains of the real world. So how do we ensure that HCPs, regulators and patients understand and value data that has been collected outside a clinical trial? ... And finally, does the unique types of data collected through real-world

  • Patient outcomes in practice: delivering value that transforms lives Patient outcomes in practice: delivering value that transforms lives

    incorporating patient-reported outcomes measures in real-world data programmes, and patient advocacy support. ... The organisations that do this first will lead the industry. As an agency, we partner with our clients in transforming lives: making

More from intelligence
Approximately 6 fully matching, plus 50 partially matching documents found.

Latest appointments

  • Astellas appoints new senior VP Astellas appoints new senior VP

    pioneered multiple real-world data endeavours and built research partnerships with academic and managed care organisations.

  • Dr Ameet Nathwani moves from Novartis to Sanofi Dr Ameet Nathwani moves from Novartis to Sanofi

    Oliver Brandicourt, Sanofi's chief executive officer, said: “Our industry is experiencing increased pressure to support reimbursement with customized data from real-world evidence, demonstrate ongoing benefit-risk of registered products

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • NHS medicines optimisation milestone

    This targeted and granular data can be cross referenced from multiple health and social care sources. ... Other useful real-world data includes diagnostic imaging datasets and prescribing data from NHS Digital, which delves down to GP surgery level.

  • Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?

    You might think this is a naïve question. It feels like it is, but if this is the case, why do marketers, brand builders, creatives and communicators from the consumer world ... formulated from third party, real world evidence and peer reviewed data.

  • VR/AR - Dr Tim Ringrose

    Data from patients provides highly valuable real world insight into compliance issues, unmet needs and patient satisfaction. .

  • Three key development areas in the management of multiple sclerosis

    Clinical trial and real-world data supporting the efficacy of disease-modifying therapies in newly diagnosed and early MS were presented at the ECTRIMS congress. ... The data showed that the majority of patients remained free from confirmed disability

  • Collaborate to Survive

    While technological advances like the fast developing fields of real-world data and artificial intelligence have great potential to positively impact healthcare systems, other changes such as an ageing population and

More from PMHub
Approximately 1 fully matching, plus 30 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Quick links

Infographics

Multimedia